News
LivaNova Announces Early Retirement of $450 Million Term Loan and Executes $125 Million Revolving Credit Facility
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced the early retirement of its $450 million five-year senior secured term loan (the Term Loan)
UnityPoint Health Selects Premier Inc. for Strategic Supply Chain Partnership
UnityPoint Health, a leading network of hospitals, clinics and home care services across the Midwest, has partnered with Premier Inc. (NASDAQ: PINC), a leading technology-driven healthcare
QIAGEN and GT Molecular Collaborate to Offer a Complete SARS-CoV-2 Wastewater Detection Solution Based on QIAcuity Digital PCR Technology
QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) and GT Molecular, a leader in providing customizable, highly sensitive digital PCR and qPCR tests based in the U.S., have started to offer a
QIAGEN und GT Molecular bieten gemeinsam eine auf dem digitalem PCR-System QIAcuity basierende Komplettlösung zum Nachweis von SARS-CoV-2 in Abwässern an
QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) und GT Molecular, ein führender Anbieter anpassbarer, hochsensitiver digitaler PCR- und qPCR-Tests mit Sitz in den USA, bieten seit Kurzem eine
QIAGEN and OncXerna Therapeutics Sign Licensing and Master Companion Diagnostic Agreements
QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) and OncXerna Therapeutics, Inc. (“OncXerna”), a precision medicine company using an innovative RNA-expression based biomarker platform to predict
QIAGEN und OncXerna Therapeutics unterzeichnen Lizenzvereinbarung und Rahmenvertrag über Begleitdiagnostikum
QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) und OncXerna Therapeutics, Inc. („OncXerna“) haben heute den Abschluss eines Rahmenvertrags über die Entwicklung eines NGS-Begleitdiagnostikums für
Merritt Hawkins Report: Nurse Practitioners Top List of Most Recruited Providers
Nurse practitioners topped the list of most recruited providers in the annual report on physician and advanced practitioner recruiting trends produced by Merritt Hawkins, a leading medical search
Premier Inc. Brands Technology and Services Platform “PINC AI™”
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today announced that it is branding its comprehensive technology and services platform “PINC AI,” effective immediately.
The
QIAGEN erhält Notfallgenehmigung der US-amerikanischen FDA für tragbaren Schnelltest, der über 30 Proben pro Stunde auf SARS-CoV-2-Antigen analysieren kann
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute bekannt, dass das Unternehmen von der U.S. Food and Drug Administration (FDA) die Notfallzulassung (EUA) für seinen QIAreach® SARS
QIAGEN receives U.S. FDA emergency use authorization for rapid portable test that can analyze over 30 samples per hour for SARS-CoV-2 antigen
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its QIAreach® SARS CoV-2
Chemed Corporation Declares Quarterly Dividend of 36 Cents
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 36-cents per share on the Company’s capital stock, payable on September 2, 2021
Premier Board of Directors Approves New $250 Million Share Repurchase Program and Increase to Quarterly Cash Dividend
Premier, Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced that its Board of Directors approved a share repurchase program under which the company may repurchase up to $250
AMN Healthcare Announces Second Quarter 2021 Results
AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its second quarter 2021
Lutheran Health Network of Indiana, LLC and Acadia Healthcare Hold Groundbreaking Ceremony for New Behavioral Health Hospital in Fort Wayne
Lutheran Health Network of Indiana, LLC and Acadia Healthcare Company today held a groundbreaking ceremony for Maple Heights Behavioral Health, a new 120-bed inpatient behavioral health facility in
Vifor Pharma reports strong H1 2021 growth, on track to meet full year guidance1
Regulatory News:
Vifor Pharma Group reported profitable revenue growth in H1 supported by a strong recovery in Ferinject® / Injectafer® with sales up 22.8% at CER as a result of improved patient
Vifor Pharma erzielt im 1. Halbjahr 2021 starkes Wachstum und bestätigt Jahresprognose1
Regulatory News:
Die Vifor Pharma Gruppe erzielte im 1. Halbjahr 2021 ein profitables Umsatzwachstum dank einer starken Erholung von Ferinject®/Injectafer® mit einem Umsatzplus von 22.8% zu kWk
Xencor Reports Second Quarter 2021 Financial Results
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today reported
Charles River Laboratories Announces Second-Quarter 2021 Results
Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the second quarter of 2021. For the quarter, revenue was $914.6 million, an increase of 34.0% from $682.6
LivaNova Prices Offering of Ordinary Shares
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced that it has priced an underwritten offering of 3,636,364 ordinary shares at a price to the
Premier Inc. to Participate in KeyBanc Capital Markets Virtual Technology Leadership Forum on August 10, 2021
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced today that members of its management team are scheduled to participate in a fireside chat at the KeyBanc Capital
LivaNova Announces Offering of Ordinary Shares
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it has commenced an underwritten offering of $300 million of its ordinary shares. LivaNova
Acadia Healthcare Reports Second Quarter 2021 Results and Increases 2021 Guidance
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the second quarter ended June 30, 2021.
Second Quarter 2021 Results
The Company reported revenue of $582.2
Xencor to Present at Upcoming Investor Conferences
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced
QIAGEN Reports Full Results for Q2 and H1 2021
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced full results for the second quarter and first half of 2021 that were in line with the preliminary announcement on July 12.
Net
QIAGEN meldet vollständige Ergebnisse für das zweite Quartal und das erste Halbjahr 2021
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute die vollständigen Ergebnisse für das zweite Quartal und das erste Halbjahr 2021 bekannt; sie entsprachen der vorläufigen